Adaptimmune Therapeutics plc (ADAP)
NASDAQ: ADAP · Real-Time Price · USD
0.2765
-0.0030 (-1.07%)
At close: Jul 21, 2025, 4:00 PM
0.2800
+0.0035 (1.27%)
Pre-market: Jul 22, 2025, 8:05 AM EDT
Adaptimmune Therapeutics Market Cap
Adaptimmune Therapeutics has a market cap or net worth of $73.29 million as of July 22, 2025. Its market cap has decreased by -71.89% in one year.
Market Cap
73.29M
Enterprise Value
62.43M
1-Year Change
-71.89%
Ranking
Category
Stock Price
$0.28
Market Cap Chart
Since March 31, 2016, Adaptimmune Therapeutics's market cap has decreased from $575.60M to $73.29M, a decrease of -87.27%. That is a compound annual growth rate of -19.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2025 | 73.40M | -46.77% |
| Dec 31, 2024 | 137.90M | -23.43% |
| Dec 29, 2023 | 180.10M | -24.71% |
| Dec 30, 2022 | 239.20M | -59.17% |
| Dec 31, 2021 | 585.90M | -29.78% |
| Dec 31, 2020 | 834.40M | 561.17% |
| Dec 31, 2019 | 126.20M | -79.02% |
| Dec 31, 2018 | 601.40M | -3.93% |
| Dec 29, 2017 | 626.00M | 118.35% |
| Dec 30, 2016 | 286.70M | -50.19% |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 692.79B |
| Johnson & Johnson | 393.87B |
| AbbVie | 334.31B |
| Novo Nordisk | 287.38B |
| UnitedHealth Group | 256.40B |
| Novartis AG | 223.49B |
| Abbott Laboratories | 215.17B |
| AstraZeneca | 214.61B |